United Therapeutics CorpNASDAQ:UTHR
- LAST PRICE266.2200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots200.0000/ 1
- Ask / Lots299.9400/ 1
- Open / Previous Close0.0000 / 266.2200
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | UTHR |
|---|---|---|
| 09:32 ET | 4789 | 261.1 |
| 09:39 ET | 281 | 261.795 |
| 09:41 ET | 200 | 262.36 |
| 09:43 ET | 712 | 263.05 |
| 09:45 ET | 3856 | 263.14 |
| 09:48 ET | 500 | 263.17 |
| 09:50 ET | 200 | 262.935 |
| 09:52 ET | 1100 | 262.88 |
| 09:54 ET | 1800 | 262.075 |
| 09:56 ET | 600 | 262.05 |
| 09:59 ET | 1500 | 261.63 |
| 10:01 ET | 1608 | 262.07 |
| 10:03 ET | 100 | 261.76 |
| 10:06 ET | 1781 | 261.73 |
| 10:08 ET | 2572 | 261 |
| 10:12 ET | 100 | 261.105 |
| 10:14 ET | 431 | 261.915 |
| 10:15 ET | 400 | 262.545 |
| 10:21 ET | 1098 | 263.185 |
| 10:24 ET | 200 | 263.18 |
| 10:26 ET | 1254 | 263.15 |
| 10:28 ET | 300 | 263.18 |
| 10:30 ET | 688 | 262.85 |
| 10:33 ET | 201 | 262.94 |
| 10:35 ET | 1083 | 263.115 |
| 10:37 ET | 1568 | 262.87 |
| 10:39 ET | 200 | 262.74 |
| 10:42 ET | 400 | 262.48 |
| 10:44 ET | 200 | 262.05 |
| 10:46 ET | 500 | 261.5 |
| 10:48 ET | 3413 | 261.5 |
| 10:51 ET | 400 | 261.19 |
| 10:53 ET | 300 | 261.5 |
| 10:55 ET | 7748 | 261.87 |
| 10:57 ET | 192 | 261.5467 |
| 11:02 ET | 800 | 262.47 |
| 11:04 ET | 2000 | 262 |
| 11:06 ET | 700 | 262 |
| 11:08 ET | 400 | 261.935 |
| 11:09 ET | 1200 | 262 |
| 11:11 ET | 300 | 262.17 |
| 11:13 ET | 400 | 262.21 |
| 11:15 ET | 100 | 262.005 |
| 11:18 ET | 800 | 262.2 |
| 11:20 ET | 100 | 262.23 |
| 11:22 ET | 2622 | 262.5 |
| 11:24 ET | 100 | 262.21 |
| 11:26 ET | 100 | 262.295 |
| 11:27 ET | 100 | 262.3 |
| 11:31 ET | 100 | 262.3 |
| 11:33 ET | 1300 | 262.515 |
| 11:38 ET | 500 | 262.5 |
| 11:42 ET | 378 | 262.46 |
| 11:45 ET | 2710 | 263.37 |
| 11:47 ET | 200 | 263.15 |
| 11:49 ET | 2909 | 262.44 |
| 12:00 ET | 200 | 262.585 |
| 12:02 ET | 106 | 262.6 |
| 12:03 ET | 1244 | 262.77 |
| 12:07 ET | 300 | 262.94 |
| 12:09 ET | 100 | 262.945 |
| 12:12 ET | 400 | 263.01 |
| 12:14 ET | 403 | 263.01 |
| 12:16 ET | 806 | 262.86 |
| 12:18 ET | 900 | 262.74 |
| 12:20 ET | 317 | 263.01 |
| 12:21 ET | 300 | 263.08 |
| 12:23 ET | 3297 | 263.06 |
| 12:25 ET | 800 | 262.95 |
| 12:27 ET | 400 | 263.48 |
| 12:30 ET | 100 | 263.47 |
| 12:32 ET | 289 | 263.1 |
| 12:36 ET | 404 | 262.965 |
| 12:39 ET | 1490 | 262.715 |
| 12:41 ET | 240 | 262.4 |
| 12:45 ET | 200 | 262.52 |
| 12:50 ET | 349 | 262.84 |
| 12:54 ET | 239 | 262.98 |
| 12:56 ET | 500 | 263.34 |
| 12:57 ET | 500 | 263.32 |
| 12:59 ET | 1200 | 263.36 |
| 01:01 ET | 839 | 263.48 |
| 01:03 ET | 1386 | 263.48 |
| 01:06 ET | 420 | 263.48 |
| 01:08 ET | 1320 | 263.31 |
| 01:10 ET | 1500 | 263.19 |
| 01:12 ET | 1400 | 263.19 |
| 01:15 ET | 997 | 263.0777 |
| 01:17 ET | 300 | 262.95 |
| 01:19 ET | 600 | 263.48 |
| 01:21 ET | 600 | 263.47 |
| 01:24 ET | 200 | 263.48 |
| 01:26 ET | 1163 | 263.45 |
| 01:28 ET | 700 | 263.17 |
| 01:32 ET | 300 | 263.7 |
| 01:33 ET | 548 | 263.78 |
| 01:35 ET | 500 | 263.78 |
| 01:37 ET | 632 | 263.69 |
| 01:39 ET | 2405 | 263.555 |
| 01:42 ET | 100 | 263.565 |
| 01:44 ET | 822 | 264.01 |
| 01:46 ET | 300 | 264.01 |
| 01:48 ET | 216 | 264.07 |
| 01:50 ET | 700 | 263.84 |
| 01:51 ET | 402 | 264.05 |
| 01:53 ET | 200 | 264.24 |
| 01:55 ET | 1000 | 264.24 |
| 01:57 ET | 2950 | 263.77 |
| 02:02 ET | 718 | 263.89 |
| 02:04 ET | 100 | 263.96 |
| 02:06 ET | 300 | 264.27 |
| 02:08 ET | 1898 | 264.1 |
| 02:09 ET | 571 | 263.99 |
| 02:11 ET | 200 | 264.14 |
| 02:13 ET | 100 | 264.17 |
| 02:15 ET | 200 | 264.28 |
| 02:18 ET | 2511 | 264.46 |
| 02:20 ET | 500 | 264.39 |
| 02:22 ET | 1669 | 264.24 |
| 02:24 ET | 1156 | 264.39 |
| 02:26 ET | 100 | 264.45 |
| 02:27 ET | 3330 | 263.79 |
| 02:29 ET | 400 | 263.98 |
| 02:31 ET | 1400 | 264.25 |
| 02:33 ET | 500 | 264.21 |
| 02:36 ET | 800 | 264.14 |
| 02:38 ET | 1581 | 263.9 |
| 02:40 ET | 1700 | 263.87 |
| 02:42 ET | 400 | 263.79 |
| 02:44 ET | 1521 | 264.225 |
| 02:45 ET | 200 | 264.31 |
| 02:47 ET | 500 | 264.32 |
| 02:49 ET | 2039 | 264.275 |
| 02:51 ET | 437 | 264.42 |
| 02:54 ET | 1700 | 264.28 |
| 02:56 ET | 1129 | 264.38 |
| 02:58 ET | 500 | 264.6 |
| 03:00 ET | 907 | 264.4725 |
| 03:02 ET | 3279 | 264.6499 |
| 03:03 ET | 311 | 264.59 |
| 03:05 ET | 200 | 264.67 |
| 03:07 ET | 1000 | 264.88 |
| 03:09 ET | 1890 | 264.84 |
| 03:12 ET | 800 | 264.92 |
| 03:14 ET | 700 | 265.055 |
| 03:16 ET | 3435 | 264.83 |
| 03:18 ET | 500 | 264.48 |
| 03:20 ET | 1116 | 264.435 |
| 03:21 ET | 3664 | 264.7 |
| 03:23 ET | 1360 | 264.55 |
| 03:25 ET | 1923 | 265.295 |
| 03:27 ET | 3118 | 264.64 |
| 03:30 ET | 1286 | 264.85 |
| 03:32 ET | 2057 | 265.25 |
| 03:34 ET | 1543 | 265.64 |
| 03:36 ET | 8390 | 265.03 |
| 03:38 ET | 4164 | 266.12 |
| 03:39 ET | 600 | 265.79 |
| 03:41 ET | 4809 | 266 |
| 03:43 ET | 1903 | 266.165 |
| 03:45 ET | 7371 | 266.245 |
| 03:48 ET | 5837 | 266.21 |
| 03:50 ET | 9669 | 266.2 |
| 03:52 ET | 5530 | 266.06 |
| 03:54 ET | 2571 | 266.31 |
| 03:56 ET | 12053 | 266.02 |
| 03:57 ET | 3782 | 266.07 |
| 03:59 ET | 126817 | 266.22 |
May 3, 2024
DJ United Therapeutics Is Maintained at Neutral by Goldman Sachs, from 12:13PM ET on Friday May 03, 2024 by Dow Jones
12:13PM ET on Friday May 03, 2024 by Dow Jones
May 2, 2024
DJ United Therapeutics Is Maintained at Outperform by Oppenheimer, from 9:10AM ET on Thursday May 02, 2024 by Dow Jones
9:10AM ET on Thursday May 02, 2024 by Dow JonesDJ United Therapeutics Price Target Maintained With a $300.00/Share by HC Wainwright & Co., from 7:07AM ET on Thursday May 02, 2024 by Dow Jones
7:07AM ET on Thursday May 02, 2024 by Dow Jones
May 1, 2024
DJ United Therapeutics Up Over 8%, on Pace for Largest Percent Increase Since November 2022 -- Data Talk, from 2:56PM ET on Wednesday May 01, 2024 by Dow Jones
2:56PM ET on Wednesday May 01, 2024 by Dow JonesUnited Therapeutics Corporation Reports First Quarter 2024 Financial Results, from 6:30AM ET on Wednesday May 01, 2024 by Dow Jones
6:30AM ET on Wednesday May 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
United Therapeutics Corp | 11.8B | 12.6x | +8.22% |
Exact Sciences Corp | 11.3B | -54.1x | --- |
Medpace Holdings Inc | 12.5B | 41.0x | +35.10% |
Biomarin Pharmaceutical Inc | 15.7B | 78.2x | --- |
Qiagen NV | 9.5B | 28.2x | +12.66% |
Neurocrine Biosciences Inc | 14.4B | 39.3x | +62.04% |
Company Information
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Contact Information
- Headquarters
- 1000 SPRING STSILVER SPRING, MD, United States 20910
- Phone
- 301-608-9292
- Fax
- 301-608-9291
Executives
- Chairman of the Board, Chief Executive Officer
- Martine Rothblatt
- President, Chief Operating Officer
- Michael Benkowitz
- Lead Independent Vice Chairman of the Board
- Christopher Patusky
- Chief Financial Officer, Treasurer
- James Edgemond
- Executive Vice President, General Counsel, Corporate Secretary
- Paul Mahon
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $11.8B |
|---|---|
Revenue (TTM) | $2.5B |
Shares Outstanding | 44.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.48 |
EPS | $21.13 |
Book Value | $127.23 |
P/E Ratio | 12.6x |
Price/Sales (TTM) | 4.7 |
Price/Cash Flow (TTM) | 10.7x |
Operating Margin | 50.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
